Jiangsu CuroVax Co., Ltd is a large modern bio-pharmaceutical enterprise specialized in research, development, production, sales in Jiangsu Province, China, and it is also a national high-tech enterprise. Established in 2011 with the registered capital of CNY189,000,000, the company is located in Changzhou National High-tech Zone, Jiangsu Province, China.
Covering an area of 52000m2, the company has the plant buildings of 41000m2, and the company now has built the rabies vaccine workshop, influenza vaccine workshop, sub-packing workshop and R&D pilot test workshop with the supporting bio-safety laboratory, analysis and testing center, animal experimental center and the large-scale animal cell culture engineering center.
The company now has 251 employees, and the current products include the split influenza vaccine, freeze-dried rabies vaccine for human use (Vero cell) under research, tetravalent split influenza vaccine, and tracheitis vaccine etc. Meanwhile, the company has a number of patented technologies to support the product development, providing high-quality human vaccines and services at home and abroad as a professional virus vaccine manufacturer.
With years of continuous research and innovation, CuroVax is gradually establishing the vaccine base with abundant production lines and excellent structure, providing high quality products and satisfying services for the public, moistening lives and protecting the public health.